Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
BMC Nephrology
Published in: BMC Nephrology 1/2009

Open Access 01-12-2009 | Research article

Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study

Authors: Bernard G Jaar, Laura C Plantinga, Deidra C Crews, Nancy E Fink, Nasser Hebah, Josef Coresh, Alan S Kliger, Neil R Powe

Published in: BMC Nephrology | Issue 1/2009

Login to get access

Abstract

Background

The use of peritoneal dialysis (PD) has declined in the United States over the past decade and technique failure is also reportedly higher in PD compared to hemodialysis (HD), but there are little data in the United States addressing the factors and outcomes associated with switching modalities from PD to HD.

Methods

In a prospective cohort study of 262 PD patients enrolled from 28 peritoneal dialysis clinics in 13 U.S. states, we examined potential predictors of switching from PD to HD (including demographics, clinical factors, and laboratory values) and the association of switching with mortality. Cox proportional hazards regression was used to assess relative hazards (RH) of switching and of mortality in PD patients who switched to HD.

Results

Among 262 PD patients, 24.8% switched to HD; with more than 70% switching within the first 2 years. Infectious peritonitis was the leading cause of switching. Patients of black race and with higher body mass index were significantly more likely to switch from PD to HD, RH (95% CI) of 5.01 (1.15–21.8) for black versus white and 1.09 (1.03–1.16) per 1 kg/m2 increase in BMI, respectively. There was no difference in survival between switchers and non-switchers, RH (95% CI) of 0.89 (0.41–1.93).

Conclusion

Switching from PD to HD occurs early and the rate is high, threatening long-term viability of PD programs. Several patient characteristics were associated with the risk of switching. However, there was no survival difference between switchers and non-switchers, reassuring providers and patients that PD technique failure is not necessarily associated with poor prognosis.
Appendix
Available only for authorised users
Literature
1.
Wu AW, Fink NE, Marsh-Manzi JV, Meyer KB, Finkelstein FO, Chapman MM, Powe NR: Changes in Quality of Life during Hemodialysis and Peritoneal Dialysis Treatment: Generic and Disease Specific Measures. J Am Soc Nephrol. 2004, 15: 743-753. 10.1097/01.ASN.0000113315.81448.CA.CrossRefPubMed
2.
Rubin HR, Fink NE, Plantinga LC, Sadler JH, Kliger AS, Powe NR: Patient Ratings of Dialysis Care With Peritoneal Dialysis vs Hemodialysis. JAMA. 2004, 291: 697-703. 10.1001/jama.291.6.697.CrossRefPubMed
3.
U.S. Renal Data System, USRDS 2007 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2007
4.
Biesen Wv, Veys N, Lameire N, Vanholder R: Why less success of the peritoneal dialysis programmes in Europe?. Nephrol Dial Transplant. 2008, 23: 1478-1481. 10.1093/ndt/gfn123.CrossRefPubMed
5.
Gokal R, King J, Bogle S, Marsh F, Oliver D, Jakubowski C, Hunt L, Baillod R, Ogg C, Ward M, Wilkinson R: Outcome in patients on continuous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of a prospective multicentre study. The Lancet. 1987, 330: 1105-1109. 10.1016/S0140-6736(87)91544-3.CrossRef
6.
Serkes KD, Blagg CR, Nolph KD, Vonesh EF, Shapiro F: Comparison of patient and technique survival in continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis: a multicenter study. Perit Dial Int. 1990, 10: 15-19.PubMed
7.
Maiorca R, Cancarini GC, Zubani R, Camerini C, Manili L, Brunori G, Movilli E: CAPD viability: a long-term comparison with hemodialysis. Perit Dial Int. 1996, 16: 276-287.PubMed
8.
Churchill DN, Thorpe KE, Vonesh EF, Keshaviah PR: Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1997, 8: 965-971.PubMed
9.
Woodrow G, Turney JH, Brownjohn AM: Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int. 1997, 17: 360-364.PubMed
10.
Szeto CC, Chow KM, Wong TY-H, Leung CB, Wang AY-M, Lui SF, Li PK: Feasibility of Resuming Peritoneal Dialysis after Severe Peritonitis and Tenckhoff Catheter Removal. J Am Soc Nephrol. 2002, 13: 1040-1045.PubMed
11.
Powe NR, Klag MJ, Sadler JH, Anderson GF, Bass EB, Briggs WA, Fink NE, Levey AS, Levin NW, Meyer KB, Rubin HR, Wu AW: Choices for healthy outcomes in caring for end stage renal disease. Semin Dial. 1996, 9: 9-11. 10.1111/j.1525-139X.1996.tb00890.x.CrossRef
12.
Kinchen KS, Sadler J, Fink N, Brookmeyer R, Klag MJ, Levey AS, Powe NR: The Timing of Specialist Evaluation in Chronic Kidney Disease and Mortality. Ann Intern Med. 2002, 137: 479-486.CrossRefPubMed
13.
Miskulin DC, Meyer KB, Athienites NV, Martin AA, Terrin N, Marsh JV, Fink NE, Coresh J, Powe NR, Klag MJ, Levey AS: Comorbidity and other factors associated with modality selection in incident dialysis patients: The CHOICE study. Am J Kidney Dis. 2002, 39: 324-336. 10.1053/ajkd.2002.30552.CrossRefPubMed
14.
Athienites NV, Miskulin DC, Fernandez G, Bunnapradist S, Simon G, Landa M, Schmid CH, Greenfield S, Levey AS, Meyer KB: Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease. Semin Dial. 2000, 13: 320-326. 10.1046/j.1525-139x.2000.00095.x.CrossRefPubMed
15.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation. Ann Intern Med. 1999, 130: 461-470.CrossRefPubMed
16.
Localio AR, Berlin JA, Ten Have TR, Kimmel SE: Adjustments for center in multicenter studies: an overview. Ann Intern Med. 2001, 135: 112-123.CrossRefPubMed
17.
Guo A, Mujais S: Patient and technique survival on peritoneal dialysis in the United States: Evaluation in large incident cohorts. Kidney Int. 2003, 64: S3-S12. 10.1046/j.1523-1755.2003.08801.x.CrossRef
18.
Jaar BG, Coresh J, Plantinga LC, Fink NE, Klag MJ, Levey AS, Levin NW, Sadler JH, Kliger A, Powe NR: Comparing the Risk for Death with Peritoneal Dialysis and Hemodialysis in a National Cohort of Patients with Chronic Kidney Disease. Ann Intern Med. 2005, 143: 174-183.CrossRefPubMed
19.
Schaubel DE, Blake PG, Fenton SS: Trends in CAPD technique failure: Canada, 1981–1997. Perit Dial Int. 2001, 21: 365-371.PubMed
20.
Foley RN, Parfrey PS, Harnett JD, Kent GM, O'Dea R, Murray DC, Barre PE: Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol. 1998, 9: 267-276. 10.1159/000017071.PubMed
21.
Jager KJ, Merkus MP, Dekker FW, Boeschoten EW, Tijssen JGP, Stevens P, Bos WJ, Krediet RT: Mortality and technique failure in patients starting chronic peritoneal dialysis: Results of the Netherlands Cooperative Study on the Adequacy of Dialysis. Kidney Int. 1999, 55: 1476-1485. 10.1046/j.1523-1755.1999.00353.x.CrossRefPubMed
22.
Abbott KC, Glanton CW, Trespalacios FC, Oliver DK, Ortiz MI, Agodoa LY, Cruess DF, Kimmel PL: Body mass index, dialysis modality, and survival: Analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int. 2004, 65: 597-605. 10.1111/j.1523-1755.2004.00385.x.CrossRefPubMed
23.
Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI: What really happens to people on long-term peritoneal dialysis?. Kidney Int. 1998, 54: 2207-2217. 10.1046/j.1523-1755.1998.00180.x.CrossRefPubMed
24.
Mujais S, Story K: Peritoneal dialysis in the US: Evaluation of outcomes in contemporary cohorts. Kidney Int Suppl. 2006, 70: S21-S26. 10.1038/sj.ki.5001912.CrossRef
25.
Maiorca R, Vonesh EF, Cavalli P, De Vecchi A, Giangrande A, La Greca G, Scarpioni LL, Bragantini L, Cancarini GC, Cantaluppi A, Castelnovo C, Castiglioni A, Poisetti P, Viglino G: A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int. 1991, 11: 118-127.PubMed
26.
Strippoli GFM, Tong A, Johnson D, Schena FP, Craig JC: Catheter-Related Interventions to Prevent Peritonitis in Peritoneal Dialysis: A Systematic Review of Randomized, Controlled Trials. J Am Soc Nephrol. 2004, 15: 2735-2746. 10.1097/01.ASN.0000141463.95561.79.CrossRefPubMed
27.
Kawaguchi Y, Hasegawa T, Nakayama M, Kubo H, Shigematu T: Issues affecting the longevity of the continuous peritoneal dialysis therapy. Kidney Int Suppl. 1997, 62: S105-S107.PubMed
28.
Fusshoeller A: Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis. Pediatric Nephrology. 2008, 23: 19-25. 10.1007/s00467-007-0541-z.CrossRefPubMed
29.
Fusshöller A, zur Nieden S, Grabensee B, Plum J: Peritoneal Fluid and Solute Transport: Influence of Treatment Time, Peritoneal Dialysis Modality, and Peritonitis Incidence. J Am Soc Nephrol. 2002, 13: 1055-1060.PubMed
30.
Korbet SM, Shih D, Cline KM, Vonesh EF: Racial differences in survival in an urban peritoneal dialysis program. Am J Kidney Dis. 1999, 34: 713-720. 10.1016/S0272-6386(99)70398-7.CrossRefPubMed
31.
Huisman RM, Nieuwenhuizen MGM, de Charro FT: Patient-related and centre-related factors influencing technique survival of peritoneal dialysis in The Netherlands. Nephrol Dial Transplant. 2002, 17: 1655-1660. 10.1093/ndt/17.9.1655.CrossRefPubMed
32.
Viglino G, Cancarini GC, Catizone L, Cocchi R, De Vecchi A, Lupo A, Salomone M, Segoloni GP, Giangrande A: Ten years experience of CAPD in diabetics: comparison of results with non-diabetics. Nephrol Dial Transplant. 1994, 9: 1443-1448.PubMed
33.
Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ: Body size and outcomes on peritoneal dialysis in the United States. Kidney Int. 2003, 64: 1838-1844. 10.1046/j.1523-1755.2003.00287.x.CrossRefPubMed
34.
McDonald SP, Collins JF, Johnson DW: Obesity Is Associated with Worse Peritoneal Dialysis Outcomes in the Australia and New Zealand Patient Populations. J Am Soc Nephrol. 2003, 14: 2894-2901. 10.1097/01.ASN.0000091587.55159.5F.CrossRefPubMed
35.
Schmekal B: Peritoneal dialysis in patients with high body-mass index. Wiener Klinische Wochenschrift. 2005, 117: 40-45. 10.1007/s00508-005-0495-8.CrossRefPubMed
36.
McDonald SP, Collins JF, Rumpsfeld M, Johnson DW: Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int. 2004, 24: 340-346.PubMed
37.
Tonelli M, Hemmelgarn B, Culleton B, Klarenbach S, Gill JS, Wiebe N, Manns B, Alberta Kidney Disease Network: Mortality of Canadians treated by peritoneal dialysis in remote locations. Kidney Int. 2007, 72: 1023-1028. 10.1038/sj.ki.5002443.CrossRefPubMed
38.
Kim GC, Vonesh EF, Korbet SM: The effect of technique failure on outcome in black patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2002, 22: 53-59.PubMed
39.
Van Biesen W, Dequidt C, Vijt D, Vanholder R, Lameire N: Analysis of the reasons for transfers between hemodialysis and peritoneal dialysis and their effect on survivals. Adv Perit Dial. 1998, 14: 90-94.PubMed
40.
Van Biesen W, Vanholder RC, Veys N, Dhondt A, Lameire NH: An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol. 2000, 11: 116-125.PubMed
41.
Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1998, 9: 1285-1292.PubMed
42.
Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S, Mexican Nephrology Collaborative Study Group: Effects of Increased Peritoneal Clearances on Mortality Rates in Peritoneal Dialysis: ADEMEX, a Prospective, Randomized, Controlled Trial. J Am Soc Nephrol. 2002, 13: 1307-1320.PubMed
43.
Szeto CC, Chow KM, Leung CB, Wong TY, Wu AK, Wang AY, Lui SF, Li PK: Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: A review of 104 cases. Kidney Int. 2001, 59: 2309-2315.CrossRefPubMed
Metadata
Title
Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study
Authors
Bernard G Jaar
Laura C Plantinga
Deidra C Crews
Nancy E Fink
Nasser Hebah
Josef Coresh
Alan S Kliger
Neil R Powe
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2009
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-10-3

Other articles of this Issue 1/2009

BMC Nephrology 1/2009 Go to the issue

Research article

Prevalence of chronic kidney disease in Thai adults: a national health survey

Research article

High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo

Research article

End-stage renal disease in young black males in a black-white population: longitudinal analysis of the Bogalusa Heart Study

Research article

Offspring of parents with Balkan Endemic Nephropathy have higher C-reactive protein levels suggestive of inflammatory processes: a longitudinal study

Research article

Age-related associations of hypertension and diabetes mellitus with chronic kidney disease

Research article

Quality of life and mortality from a nephrologist's view: a prospective observational study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits